Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 984 | 1,055 | 370 | 522 | 449 |
| Gross Profit | 984 | 1,055 | 370 | 522 | 449 |
| Operating Expenses | 8,078 | 10,286 | 11,797 | 11,465 | 13,208 |
| Operating Income | -7,094 | -9,231 | -11,427 | -10,944 | -12,759 |
| Other Income | 104 | 122 | 160 | 170 | 200 |
| Pre-tax Income | -6,990 | -9,109 | -11,267 | -10,773 | -12,559 |
| Income Tax | N/A | 413 | N/A | N/A | N/A |
| Net Income Continuous | -6,990 | -9,522 | -11,267 | -11,598 | -12,559 |
| Net Income | $-6,990 | $-9,522 | $-11,267 | $-11,598 | $-12,559 |
| EPS Basic Total Ops | -0.31 | -0.46 | -0.54 | -0.59 | -0.62 |
| EPS Basic Continuous Ops | -0.31 | -0.46 | -0.54 | -0.57 | -0.62 |
| EPS Diluted Total Ops | -0.31 | -0.46 | -0.54 | -0.59 | -0.62 |
| EPS Diluted Continuous Ops | -0.31 | -0.46 | -0.54 | -0.57 | -0.62 |
| EBITDA(a) | $-6,899 | $-9,026 | $-11,222 | $-10,740 | $-12,565 |